Patent details

EP2364137 Title: PHARMACEUTICAL SUSPENSION

Basic Information

Publication number:
EP2364137
PCT Application Number:
US2009066570
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097682843
PCT Publication Number:
WO2010065730
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL SUSPENSION
French Title of Invention:
SUSPENSION PHARMACEUTIQUE
German Title of Invention:
PHARMAZEUTISCHE SUSPENSION
SPC Number:

Dates

Filing date:
03/12/2009
Grant date:
29/03/2017
EP Publication Date:
14/09/2011
PCT Publication Date:
10/06/2010
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/03/2017
EP B1 Publication Date:
29/03/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/12/2018
Expiration date:
03/12/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/03/2017
 
 

Name:
NOVARTIS AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

Name:
KABRA, Bhagwati P.
Address:
United States (US)

Priority

Priority Number:
120081 P
Priority Date:
05/12/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/10; A61K 47/10;

Publication

European Patent Bulletin

Issue number:
201713
Publication date:
29/03/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
28/11/2017
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages
30/04/2019 Outgoing Correspondence 1